This workshop provides an overview of considerations for practitioners when prescribing medications for patients with chronic kidney disease (CKD). Infection treatment agents, pain relievers, biologic mediators, and anticoagulants and the potential effects on kidney function in CKD patients are addressed. Continuing Education Instructions and Disclosure Information Contact hours available until 9/24/2020.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure: Planning Committee Disclosures: Elizabeth St. John – Employee, Fresenius Kidney Care
There are no other disclosures to declare. Commercial Support and Sponsorship: No commercial support or sponsorship declared. Accreditation Statement: American Nephrology Nurses Association – Provider is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Learning Outcome: APNs will state an increased ability to utilize biologic mediators when prescribing and utilizing biologic mediators.
PhD, RN, ACNP-BC,
Clinical Associate Professor,
University of Texas at Arlington